Citations (114)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Touraj Shokati, Marcel Hartmann, Baharak Davari, Jost Klawitter, Jelena Klawitter & Uwe Christians. (2020) Temsirolimus metabolic pathways revisited. Xenobiotica 50:6, pages 640-653.
Read now
Read now
Claudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni & Alberto Corsini. (2020) Treatment of dyslipidemia in kidney transplantation. Expert Opinion on Drug Safety 19:3, pages 257-267.
Read now
Read now
Pingping Dong, Fengmei Hao, Shufeng Dai & Lin Tian. (2018) Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways. Journal of Receptors and Signal Transduction 38:1, pages 83-88.
Read now
Read now
Gabriel Fernandes-Silva, Mayara Ivani de Paula & Érika B. Rangel. (2017) mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions. Expert Opinion on Drug Metabolism & Toxicology 13:4, pages 367-385.
Read now
Read now
Articles from other publishers (110)
Nele Kanzelmeyer. (2023) Umstellung auf einen mTOR-Inhibitor zur Verringerung von CMV-Rezidiven bei Nierentransplantatempfängern unter präventiver BehandlungConversion to mTOR inhibitor to reduce CMV recurrence in kidney transplant recipients receiving preemptive treatment. Die Nephrologie.
Crossref
Crossref
Aparna Wagle Shukla, Caroline Lunny, Omar Mahboob, Uzair Khalid, Malea Joyce, Nivedita Jha, Nandakumar Nagaraja & Ashutosh M. Shukla. (2023) Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature. Drugs in R&D 23:4, pages 301-329.
Crossref
Crossref
Jing Han Hong, Chern Han Yong, Hong Lee Heng, Jason Yongsheng Chan, Mai Chan Lau, Jianfeng Chen, Jing Yi Lee, Abner Herbert Lim, Zhimei Li, Peiyong Guan, Pek Lim Chu, Arnoud Boot, Sheng Rong Ng, Xiaosai Yao, Felicia Yu Ting Wee, Jeffrey Chun Tatt Lim, Wei Liu, Peili Wang, Rong Xiao, Xian Zeng, Yichen Sun, Joanna Koh, Xiu Yi Kwek, Cedric Chuan Young Ng, Poramate Klanrit, Yaojun Zhang, Jiaming Lai, David Wai Meng Tai, Chawalit Pairojkul, Simona Dima, Irinel Popescu, Sen-Yung Hsieh, Ming-Chin Yu, Joe Yeong, Sarinya Kongpetch, Apinya Jusakul, Watcharin Loilome, Patrick Tan, Jing Tan & Bin Tean Teh. (2023) Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies. Gut, pages gutjnl-2023-330483.
Crossref
Crossref
Suwasin Udomkarnjananun, Thanee Eiamsitrakoon, Brenda C. M. de Winter, Teun van Gelder & Dennis A. Hesselink. (2023) Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements?. British Journal of Clinical Pharmacology.
Crossref
Crossref
Shima Shirzad, Farzaneh Vafaee & Fatemeh Forouzanfar. (2023) The Neuroprotective Effects and Probable Mechanisms of Everolimus in a Rat Model of Intracerebral Hemorrhage. Cellular and Molecular Neurobiology 43:8, pages 4219-4230.
Crossref
Crossref
Neil Palmisiano, Grace Jeschke, Lindsay Wilde, Onder Alpdogan, Matthew Carabasi, Joanne Filicko-O’Hara, Dolores Grosso, Thomas Klumpp, Ubaldo Martinez, John Wagner, Martin P. Carroll, Alexander Perl & Margaret Kasner. (2023) A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers 15:21, pages 5129.
Crossref
Crossref
Touraj Shokati, Seth H. Drake, Wanzhu Zhao, Jost Klawitter, Jelena Klawitter & Uwe Christians. (2023) Structural Identification of Zotarolimus (ABT-578) Metabolites Generated by Human Liver Microsomes Using Ion-Trap and High-Resolution Time-of-Flight Mass Spectrometry in Combination with the Analysis of Fragmentation Patterns. Metabolites 13:10, pages 1093.
Crossref
Crossref
Juliana Toniato de Rezende FreschiMarina Pontello CristelliLaila Almeida VianaKlaus Nunes FicherMonica Rika NakamuraHenrique ProençaYasmim Cardoso DreigeRenato de MarcoMaria Gerbase de LimaRenato Demarchi ForestoWilson Ferreira AguiarJose Medina-PestanaHelio Tedesco-Silva. (2023) A Head-to-head Comparison of De Novo Sirolimus or Everolimus Plus Reduced-dose Tacrolimus in Kidney Transplant Recipients: A Prospective and Randomized Trial. Transplantation.
Crossref
Crossref
Alysia Cox, Madelynn Tung, Hui Li, Kenneth R. Hallows & Eun Ji Chung. (2023) In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease. SLAS Technology 28:4, pages 223-229.
Crossref
Crossref
Helio Milani Pegado, Adailson Siqueira, Joshua Navarajasegaran, Luiz Alberto Benvenuti, Claudia Regina Pinheiro Castro, Santiago Raul Arrieta, Paulo Sampaio Gutierrez, Marisa Dolhnikoff, Vera Demarchi Aiello, Marcelo Biscegli Jatene & Estela Azeka. (2023) Case Report: The Challenge for Diagnosis of Myocarditis and Transplant Rejection After COVID Infection in a Heart-Transplanted Adolescent. Transplantation Proceedings 55:6, pages 1449-1450.
Crossref
Crossref
Rabea Asleh, Hilmi Alnsasra, Mauricio A. Villavicencio, Richard C. Daly & Sudhir S. Kushwaha. 2011. Comprehensive Physiology. Comprehensive Physiology
4719
4765
.
Olabayo H. Ajetunmobi, Ashok K. Chaturvedi, Hamid Badali, Alessandra Vaccaro, Laura Najvar, Floyd L. WormleyJrJr, Nathan P. Wiederhold, Thomas F. Patterson & Jose L. Lopez‐Ribot. (2023)
Screening the medicine for malaria venture's Pandemic Response Box to identify novel inhibitors of
Candida albicans
and
Candida auris
biofilm formation
. APMIS.
Crossref
Crossref
Akihiro Maenaka, Kohei Kinoshita, Hidetaka Hara & David K. C. Cooper. (2023) The case for the therapeutic use of mechanistic/mammalian target of rapamycin (mTOR) inhibitors in xenotransplantation. Xenotransplantation 30:3.
Crossref
Crossref
David M. Newland, Beatrice E. Rosete, Yuk M. Law, Mariska S. Kemna, Erin L. Albers, Borah J. Hong, Humera Ahmed, Kathryn L. Spencer & Joshua M. Friedland‐Little. (2023) Assessment of the adverse effects of sirolimus versus everolimus in pediatric heart transplant recipients. Pediatric Transplantation 27:3.
Crossref
Crossref
Aleksandra Wilk, Dagmara Szypulska-Koziarska, Dorota Oszutowska-Mazurek, Alexander Baraniskin, Joanna Kabat-Koperska, Przemyslaw Mazurek & Barbara Wiszniewska. (2023) Prenatal Exposition to Different Immunosuppressive Protocols Results in Vacuolar Degeneration of Hepatocytes. Biology 12:5, pages 654.
Crossref
Crossref
Cristiano Ialongo, Maria Sapio & Antonio Angeloni. (2023) Analytical Performance of the New Siemens Affinity Chrome-Mediated Immunoassay Everolimus Assay and Its Interchangeability With the Thermo Quantitative Microsphere System for Routine Therapeutic Drug Monitoring of Patients After Solid Organ Transplantation. Therapeutic Drug Monitoring 45:2, pages 217-222.
Crossref
Crossref
Sheng Wang, Zhaoyun Cheng, Xianjie Chen, Guoqing Lu, Xiliang Zhu & Zhenchang Qi. (2023) Poly(Lactic-Co-Glycolic Acid) (PLGA) Nanoparticles Loaded with FK506 Inhibits Acute Heart Transplantation Rejection via Regulation of Monocyte Dendritic Cells Receptor. Journal of Biomedical Nanotechnology 19:3, pages 510-517.
Crossref
Crossref
Yasutaka Okita, Maiko Yoshimura, Yoshinori Katada, Yukihiko Saeki & Shiro Ohshima. (2023) A mechanistic target of rapamycin inhibitor, everolimus safely ameliorated lupus nephritis in a patient complicated with tuberous sclerosis. Modern Rheumatology Case Reports 7:1, pages 47-51.
Crossref
Crossref
Kunal S. Parikh, Aditya Josyula, Takahiro Inoue, Takuma Fukunishi, Huaitao Zhang, Revaz Omiadze, Richard Shi, Youseph Yazdi, Justin Hanes, Laura M. Ensign & Narutoshi Hibino. (2023) Nanofiber-coated, tacrolimus-eluting sutures inhibit post-operative neointimal hyperplasia in rats. Journal of Controlled Release 353, pages 96-104.
Crossref
Crossref
Noriaki Sato, Atsuko Shiraki, Keita P. Mori, Kaoru Sakai, Long Tan, Yoshinori Takemura, Yasushi Okuno, Kazunari Tanabe & Kimiyasu Shiraki. (2022) Everolimus reduces BK polyomavirus infection by suppressing its replication and spread of infection. Antiviral Research 208, pages 105456.
Crossref
Crossref
Frederike Franke, Lutz Renders, Michael Linecker & Felix Braun. (2022) Immunsuppression nach Organtransplantation:
Essentials. Transfusionsmedizin 12:04, pages 233-246.
Crossref
Crossref
Aly Elezaby, Ryan Dexheimer & Karim Sallam. (2022) Cardiovascular effects of immunosuppression agents. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Elias David‐Neto, Marcelo Paes Menezes Filho, Ítalo José Araújo Silveira de Sá, Fabiana Agena, José Lázaro de Andrade & Flávio Jota de Paula. (2022) The impact of mTOR inhibitors in the regression of left ventricular hypertrophy in elderly kidney transplant recipients. Clinical Transplantation 36:8.
Crossref
Crossref
Chetan Velagapudi & Sreekumar Madassery. (2022) Drug-Eluting Stents. Seminars in Interventional Radiology 39:04, pages 400-405.
Crossref
Crossref
Fatemeh Forouzanfar, Payam Razavi Ebrahimi & Hamid Reza Sadeghnia. (2022) Neuroprotection of Everolimus Against Focal Cerebral Ischemia-Reperfusion Injury in Rats. Journal of Stroke and Cerebrovascular Diseases 31:8, pages 106576.
Crossref
Crossref
Patrik Oleksak, Eugenie Nepovimova, Zofia Chrienova, Kamil Musilek, Jiri Patocka & Kamil Kuca. (2022) Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021). European Journal of Medicinal Chemistry 238, pages 114498.
Crossref
Crossref
Sebastian Wolf, Verena S. Hoffmann, Florian Sommer, Matthias Schrempf, Mingming Li, Martin Ryll, Ulrich Wirth, Matthias Ilmer, Jens Werner & Joachim Andrassy. (2022) Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation—A Network Meta-Analysis. Journal of Clinical Medicine 11:14, pages 4216.
Crossref
Crossref
Jiale Liu, Minjie Luo, Siyuan Lv, Shaohua Tao, Zhu Wu, Lihua Yu, Danna Lin, Lulu Huang, Li Wu, Xu Liao, Juan Zi, Xiaorong Lai, Yuting Yuan, Wangming Zhang & Lihua Yang. (2022) Case Report: Reversible Hyperglycemia Following Rapamycin Treatment for Atypical Choroid Plexus Papilloma in an Infant. Frontiers in Endocrinology 13.
Crossref
Crossref
Fahad Aziz, Margaret Jorgenson, Neetika Garg, Sandesh Parajuli, Maha Mohamed, Farhan Raza, Didier Mandelbrot, Arjang Djamali & Ravi Dhingra. (2022) New Approaches to Cardiovascular Disease and Its Management in Kidney Transplant Recipients. Transplantation 106:6, pages 1143-1158.
Crossref
Crossref
Zhiquan Xiang, Klaudia KurandaWilliam QuinnAreski Chekaoui, Robert Ambrose, Mohadeseh Hasanpourghai, Mikhail Novikov, Dakota Newman, Christina Cole, Xiangyang Zhou, Federico MingozziHildegund C.J. Ertl. (2022) The Effect of Rapamycin and Ibrutinib on Antibody Responses to Adeno-Associated Virus Vector-Mediated Gene Transfer. Human Gene Therapy 33:11-12, pages 614-624.
Crossref
Crossref
Karolina Chmielnicka, Zbigniew Heleniak & Alicja Dębska-Ślizień. (2022) Dyslipidemia in Renal Transplant Recipients. Transplantology 3:2, pages 188-199.
Crossref
Crossref
Dominique F. Leitner, Evgeny Kanshin, Manor Askenazi, Yik Siu, Daniel Friedman, Sasha Devore, Drew Jones, Beatrix Ueberheide, Thomas Wisniewski & Orrin Devinsky. (2022) Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia. PLOS ONE 17:5, pages e0268597.
Crossref
Crossref
Matthew J. Hagan, Robert Shenkar, Abhinav Srinath, Sharbel G. Romanos, Agnieszka Stadnik, Mark L. Kahn, Douglas A. Marchuk, Romuald Girard & Issam A. Awad. (2022) Rapamycin in Cerebral Cavernous Malformations: What Doses to Test in Mice and Humans. ACS Pharmacology & Translational Science 5:5, pages 266-277.
Crossref
Crossref
Frederike Franke, Lutz Renders, Michael Linecker & Felix Braun. (2022) Immunsuppression nach Organtransplantation: Essentials. Allgemein- und Viszeralchirurgie up2date 16:02, pages 149-164.
Crossref
Crossref
Yi Luo, Fei Teng, Hong Fu & Guo-Shan Ding. (2022) Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World Journal of Gastrointestinal Oncology 14:1, pages 163-180.
Crossref
Crossref
Giulia Jannone, Isabelle Scheers, Françoise Smets, Xavier Stephenne & Etienne M Sokal. (2022) Everolimus is Safe as a Second-/Third-Line Therapy in Pediatric Autoimmune Hepatitis. JPGN Reports 3:3, pages e227.
Crossref
Crossref
Bernd Mühlbauer & Wolf-Dieter Ludwig. 2022. Arzneiverordnungs-Report 2022. Arzneiverordnungs-Report 2022
439
447
.
Isadora Zago Miotto & Walmar Roncalli Pereira de Oliveira. 2022. Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients. Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients
47
67
.
Christoph Hertzberg & David Neal Franz. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
3721
3751
.
Sarah Bernard, Andrew C. Poon, Peyton M. Tam & Anthony J. Mutsaers. (2021) Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells. BMC Veterinary Research 17:1.
Crossref
Crossref
Incheon Kang, Jae Geun Lee, Sung Hoon Choi, Hyun Jeong Kim, Dai Hoon Han, Gi Hong Choi, Myoung Soo Kim, Jin Sub Choi, Soon Il Kim & Dong Jin Joo. (2021) Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma. Clinical and Molecular Hepatology 27:4, pages 589-602.
Crossref
Crossref
Narin Ozturk, Dilek Ozturk Civelek, Serap Sancar, Engin Kaptan, Zeliha Pala Kara & Alper Okyar. (2021) Dosing-time dependent testicular toxicity of everolimus in mice. European Journal of Pharmaceutical Sciences 165, pages 105926.
Crossref
Crossref
Suwasin Udomkarnjananun, Marith I. Francke, Brenda C.M. De Winter, Midas B. Mulder, Carla C. Baan, Herold J. Metselaar, Caroline M. den Hoed & Dennis A. Hesselink. (2021) Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology. Best Practice & Research Clinical Gastroenterology 54-55, pages 101756.
Crossref
Crossref
Yang Zhao, Yu Liu, Lin Zhou, Guo-Sheng Du & Qiang He. (2021) Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 13:9, pages 953-966.
Crossref
Crossref
Mohamed Bikhet, Hayato Iwase, Takayuki Yamamoto, Abhijit Jagdale, Jeremy B. Foote, Mohamed Ezzelarab, Douglas J. Anderson, Jayme E. Locke, Devin E. Eckhoff, Hidetaka Hara & David K.C. Cooper. (2021) What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?. Transplantation 105:6, pages 1143-1155.
Crossref
Crossref
Subhajit Maity & Abhik Saha. (2021) Therapeutic Potential of Exploiting Autophagy Cascade Against Coronavirus Infection. Frontiers in Microbiology 12.
Crossref
Crossref
Majda Sahman, Snezana Mugosa & Nemanja Rancic. (2021) Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study. Frontiers in Public Health 9.
Crossref
Crossref
Rachel Y. Chow, Taylor M. Levee, Gurleen Kaur, Daniel P. Cedeno, Linda T. Doan & Scott X. Atwood. (2020) MTOR promotes basal cell carcinoma growth through atypical PKC. Experimental Dermatology 30:3, pages 358-366.
Crossref
Crossref
Alexandra P. M. Cloherty, Nienke H. van Teijlingen, Tracy-Jane T. H. D. Eisden, John L. van Hamme, Anusca G. Rader, Teunis B. H. Geijtenbeek, Renée R. C. E. Schreurs & Carla M. S. Ribeiro. (2021) Autophagy-enhancing drugs limit mucosal HIV-1 acquisition and suppress viral replication ex vivo. Scientific Reports 11:1.
Crossref
Crossref
Isadora Zago Miotto, Bruno de Castro e Souza, Stephen K. Tyring & Walmar Roncalli Pereira de Oliveira. (2021) Immunosuppressant-induced cutaneous drug reactions in solid organ transplant recipients. Transplant Immunology 64, pages 101355.
Crossref
Crossref
Chang-Ching Wei, Yu-Ping Hsiao, Shuo-Yan Gau, Yue-Ting Wu, Chi-Tang Wu, Meng-Hsuan Wu & Jeng-Dau Tsai. (2021) The Efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients Treated for Renal Angiomyolipoma/Subependymal Giant Cell Astrocytoma. Dermatology 237:3, pages 444-449.
Crossref
Crossref
Christopher McCormick & Craig Martin McKittrick. 2021. Drug Delivery Devices and Therapeutic Systems. Drug Delivery Devices and Therapeutic Systems
107
127
.
Farhad Rikhtegar Nezami, Lambros S. Athanasiou & Elazer R. Edelman. 2021. Biomechanics of Coronary Atherosclerotic Plaque. Biomechanics of Coronary Atherosclerotic Plaque
595
631
.
Bernd Mühlbauer & Wolf-Dieter Ludwig. 2021. Arzneiverordnungs-Report 2021. Arzneiverordnungs-Report 2021
499
507
.
Nida Siddiqi & Alesa Campbell. 2021. Challenges in Pediatric Kidney Transplantation. Challenges in Pediatric Kidney Transplantation
305
356
.
Zhijun Sun, Abdul Haseeb Khan & Xiao-Li Tian. 2021. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging
535
544
.
Jamael Hoosain & Eman Hamad. 2022. Pharmacology of Immunosuppression. Pharmacology of Immunosuppression
337
348
.
Rochelle Liverman, Mary Moss Chandran & Barrett Crowther. (2021) Considerations and controversies of pharmacologic management of the pediatric kidney transplant recipient. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:1, pages 77-102.
Crossref
Crossref
Gaetano Ciancio, Jeffrey J. Gaynor, Giselle Guerra, David Roth, Linda Chen, Warren Kupin, Adela Mattiazzi, Mariella Ortigosa‐Goggins, Lissett Moni & George W. BurkeIIIIII. (2020) Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low‐dose corticosteroids in primary kidney transplantation: 18‐year results. Clinical Transplantation 34:12.
Crossref
Crossref
Wiebke Theilmann, Birthe Gericke, Alina Schidlitzki, Syed Muhammad Muneeb Anjum, Saskia Borsdorf, Timon Harries, Steven L. Roberds, Dean J. Aguiar, Daniela Brunner, Steven C. Leiser, Dekun Song, Doriano Fabbro, Petra Hillmann, Matthias P. Wymann & Wolfgang Löscher. (2020) Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex. Neuropharmacology 180, pages 108297.
Crossref
Crossref
Cecilia Zavala-Tecuapetla, Manola Cuellar-Herrera & Hiram Luna-Munguia. (2020) Insights into Potential Targets for Therapeutic Intervention in Epilepsy. International Journal of Molecular Sciences 21:22, pages 8573.
Crossref
Crossref
Filip Janku, Haeseong Park, S. Greg Call, Kiran Madwani, Yasuhiro Oki, Vivek Subbiah, David S. Hong, Aung Naing, Vivianne M. Velez-Bravo, Tamara G. Barnes, Fredrick B. Hagemeister, Gerald S. Falchook, Daniel D. Karp, Jennifer J. Wheler, Sarina A. Piha-Paul, Ignacio Garrido-Laguna, Elizabeth J. Shpall, Luis E. Fayad, Sattva S. Neelapu, Funda Meric-Bernstam, Razelle Kurzrock & Michelle A. Fanale. (2020) Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma. Clinical Cancer Research 26:21, pages 5579-5587.
Crossref
Crossref
Mokhalad Alghrairi, Nasri Sulaiman & Saad Mutashar. (2020) Health Care Monitoring and Treatment for Coronary Artery Diseases: Challenges and Issues. Sensors 20:15, pages 4303.
Crossref
Crossref
Maria Elena Mateos, Eduardo López‐Laso, Josefina Vicente, Rosa Ortega, Fernando Vázquez & Juan Luis Pérez‐Navero. (2020) Response to everolimus of a progressive plexiform neurofibroma in Neurofibromatosis type 1. Pediatrics International 62:7, pages 857-859.
Crossref
Crossref
Mara C. Ebeling, Jorge R. Polanco, Jun Qu, Chengjian Tu, Sandra R. Montezuma & Deborah A. Ferrington. (2020) Improving retinal mitochondrial function as a treatment for age-related macular degeneration. Redox Biology 34, pages 101552.
Crossref
Crossref
Takaaki YamadaMengyu ZhangSatohiro Masuda. (2020) Significance of Ethnic Factors in Immunosuppressive Therapy Management After Organ Transplantation. Therapeutic Drug Monitoring 42:3, pages 369-380.
Crossref
Crossref
Björn Schniedewind, Eric J. MeyerUwe Christians. (2020) Long-Term Performance of Laboratory-Developed Liquid Chromatography–Tandem Mass Spectrometry Tests and a Food and Drug Administration–Approved Immunoassay for the Therapeutic Drug Monitoring of Everolimus. Therapeutic Drug Monitoring 42:3, pages 421-426.
Crossref
Crossref
Felicity Lee, Vidhya Nair & Sharon Chih. (2020) Cardiac allograft vasculopathy: Insights on pathogenesis and therapy. Clinical Transplantation 34:3.
Crossref
Crossref
Ernesto Paoletti, Franco Citterio, Alberto Corsini, Luciano Potena, Paolo Rigotti, Silvio Sandrini, Elisabetta Bussalino & Giovanni Stallone. (2019) Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review. Journal of Nephrology 33:1, pages 69-82.
Crossref
Crossref
Lavanya Bellumkonda & Jignesh Patel. (2019) Recent advances in the role of mammalian target of rapamycin inhibitors on cardiac allograft vasculopathy. Clinical Transplantation 34:1.
Crossref
Crossref
Ahmed M. Alkhunaizi, Thamer H. Al-Khouzaie & Ahmed I. Alsagheir. (2020) Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus. Respiratory Medicine Case Reports 30, pages 101109.
Crossref
Crossref
Viktorija Gurskytė, Ingrida Zeleckienė, Vygantė Maskoliūnaitė, Ugnius Mickys & Virginija Šileikienė. (2020) Successful treatment of diffuse pulmonary lymphangiomatosis with sirolimus. Respiratory Medicine Case Reports 29, pages 101014.
Crossref
Crossref
Ulrich Schwabe. 2020. Arzneiverordnungs-Report 2020. Arzneiverordnungs-Report 2020
593
600
.
Christoph Hertzberg & David Neal Franz. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
32
.
Georgina Waldman, Stephen A. Rawlings, Janice Kerr, Irine Vodkin, Saima Aslam, Cathy Logan, Jennifer Dan, Sanjay Mehta, Lucas Hill & Maile Y. Karris. (2019) Successful optimization of antiretroviral regimens in treatment‐experienced people living with HIV undergoing liver transplantation. Transplant Infectious Disease 21:6.
Crossref
Crossref
Rajesh M. Jagirdar, Andreas Bozikas, Sotirios G. Zarogiannis, Maria Bartosova, Claus Peter Schmitt & Vassilios Liakopoulos. (2019) Encapsulating Peritoneal Sclerosis: Pathophysiology and Current Treatment Options. International Journal of Molecular Sciences 20:22, pages 5765.
Crossref
Crossref
Karlton Wong, John Shen, Sarah D’Ambruoso, Dimitrios Stefanoudakis & Alexandra Drakaki. (2019) Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Metastatic Cancer Post Solid Organ Transplantation: A Case Report and Review of the Literature. Transplantation Proceedings 51:9, pages 3053-3058.
Crossref
Crossref
Maryam Ghadimi, Zinat Mohammadpour, Simin Dashti-Khavidaki & Alireza Milajerdi. (2019) m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 75:11, pages 1471-1480.
Crossref
Crossref
Jianglong Kong, Kai Wu, Ying Ji, Kui Chen, Jiaxin Zhang, Hui Sun, Yuelan Liang, Wei Liang, Yanan Chang, Jenny Cheng, Junmao Tong, Juan Li, Gengmei Xing & Guogang Chen. (2019) Enhanced Bioavailability by Orally Administered Sirolimus Nanocrystals. ACS Applied Bio Materials 2:10, pages 4612-4621.
Crossref
Crossref
Tavakol, Ashrafizadeh, Deng, Azarian, Abdoli, Motavaf, Poormoghadam, Khanbabaei, Afshar, Mandegary, Pardakhty, Yap, Mohammadinejad & Kumar. (2019) Autophagy Modulators: Mechanistic Aspects and Drug Delivery Systems. Biomolecules 9:10, pages 530.
Crossref
Crossref
Marco Ferrone, Yanping Cheng & Juan F. Granada. (2019) Current concepts regarding drug dosing for peripheral stents. The Journal of Cardiovascular Surgery 60:4.
Crossref
Crossref
Claudia Sommerer, Barbara Suwelack, Duska Dragun, Peter Schenker, Ingeborg A. Hauser, Oliver Witzke, Christian Hugo, Nassim Kamar, Pierre Merville, Martina Junge, Friedrich Thaiss, Björn Nashan, Eric Almartine, Jacques Dantal, Duska Dragun, Thorsten Feldkamp, Ingeborg A. Hauser, Marc Hazzan, Nils Heyne, Christian Hugo, Nassim Kamar, Philippe Lang, Frank Lehner, Yannick Le Meur, Jens Lutz, Pierre Merville, Emmanuel Morelon, Bruno Moulin, Christiane Mousson, Anja Muehlfeld, Björn Nashan, Przemyslaw Pisarski, Eric Rondeau, Peter Schenker, Claudia Sommerer, Barbara Suwelack, Friedrich Thaiss, Antoine Thierry, Michael Wiesener & Oliver Witzke. (2019) An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients. Kidney International 96:1, pages 231-244.
Crossref
Crossref
Dongyun Zhang, Jennifer S Way, Xinhai Zhang, Mareninov Sergey, Marvin Bergsneider, Marilene B Wang, William H Yong & Anthony P Heaney. (2019) Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism 104:6, pages 1929-1936.
Crossref
Crossref
M. Bevacqua, F. Baldo, S. Pastore, E. Valencic, Alberto Tommasini, A. Maestro, M. Rabusin, A. Arbo & E. Barbi. (2019) Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature. Pediatric Drugs 21:3, pages 185-193.
Crossref
Crossref
Opas Traitanon, James M. Mathew, Aneesha Shetty, Sai Vineela Bontha, Daniel G. Maluf, Yvonne El Kassis, Sook H. Park, Jing Han, M. Javeed Ansari, Joseph R. Leventhal, Valeria Mas & Lorenzo Gallon. (2019) Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen—Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil. PLOS ONE 14:5, pages e0216300.
Crossref
Crossref
Sam E. Grigg, Gino L. Sarri, Paul J. Gow & Neville D. Yeomans. (2019) Systematic review with meta‐analysis: sirolimus‐ or everolimus‐based immunosuppression following liver transplantation for hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 49:10, pages 1260-1273.
Crossref
Crossref
Stephen Cerni, Dylan Shafer, Kimberly To & Vishwanath Venketaraman. (2019) Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in Mycobacterium tuberculosis Infection. Journal of Clinical Medicine 8:2, pages 232.
Crossref
Crossref
Ulrich Schwabe & W. Jens Zeller. 2019. Arzneiverordnungs-Report 2019. Arzneiverordnungs-Report 2019
741
748
.
Zhijun Sun, Abdul Haseeb Khan & Xiao-Li Tian. 2019. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging
1
10
.
Joyce T. Yuan, Amanda R. Twigg & Sarah T. Arron. 2019. Evidence-Based Procedural Dermatology. Evidence-Based Procedural Dermatology
1057
1071
.
Yoon-Dong Park, Joseph N. Jarvis, Guowu Hu, Sarah E. Davis, Jin Qiu, Nannan Zhang, Christopher Hollingsworth, Angela Loyse, Paul J. Gardina, Tibor Valyi-Nagy, Timothy G. Myers, Thomas S. Harrison, Tihana Bicanic & Peter R. Williamson. (2018) Transcriptional Profiling of Patient Isolates Identifies a Novel TOR/Starvation Regulatory Pathway in Cryptococcal Virulence. mBio 9:6.
Crossref
Crossref
Tracey Ying, Germaine Wong, Wai Lim, John Kanellis, Helen Pilmore, Scott Campbell, Rosemary Masterson, Rowan Walker, Philip O'Connell, Graeme Russ & Steven Chadban. (2018) De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage study. American Journal of Transplantation 18:12, pages 2977-2986.
Crossref
Crossref
Johannes Korth, Olympia E. Anastasiou, Jens Verheyen, Julia Dickow, Helene Sertznig, Nicola Frericks, Barbara Bleekmann, Andreas Kribben, Alexandra Brinkhoff, Benjamin Wilde, Kathrin Sutter, Ulf Dittmer, Sandra Ciesek, Oliver Witzke & Marek Widera. (2018) Impact of immune suppressive agents on the BK-Polyomavirus non coding control region. Antiviral Research 159, pages 68-76.
Crossref
Crossref
Claudia Brandt, Petra Hillmann, Andreas Noack, Kerstin Römermann, Leon A. Öhler, Denise Rageot, Florent Beaufils, Anna Melone, Alexander M. Sele, Matthias P. Wymann, Doriano Fabbro & Wolfgang Löscher. (2018) The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy. Neuropharmacology 140, pages 107-120.
Crossref
Crossref
Serena Patel, Michel H. Mendler, Mark A. Valasek & Shirley M. Tsunoda. (2018) Drug-Induced Liver Injury Associated with the Use of Everolimus in a Liver Transplant Patient. Case Reports in Transplantation 2018, pages 1-5.
Crossref
Crossref
Helio Tedesco Silva. (2018) The Long Journey of mTOR Inhibitors and the Long Path That Is Still Ahead. Transplantation 102:2S, pages S1-S2.
Crossref
Crossref
Björn Nashan. (2018) mTOR Inhibition and Clinical Transplantation. Transplantation 102:2S, pages S19-S26.
Crossref
Crossref
Dae-Hyun Lee & Jose M de la Torre Hernandez. (2018) The Newest Generation of Drug-eluting Stents and Beyond. European Cardiology Review 13:1, pages 54.
Crossref
Crossref
Ming-Tao Yang, Yi-Chin Lin, Whae-Hong Ho, Chao-Lin Liu & Wang-Tso Lee. (2017) Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures. Journal of Neuroinflammation 14:1.
Crossref
Crossref
Suchitra Mohanty, Amit Kumar, Piyanki Das, Sushil Kumar Sahu & Tathagata Choudhuri. (2017) Multi-targeted therapy of everolimus in Kaposi’s sarcoma associated herpes virus infected primary effusion lymphoma. Apoptosis 22:9, pages 1098-1115.
Crossref
Crossref
Nina Weiler, Nigar Bilge, Sven Troetschler, Johannes Vermehren, Andreas Anton Schnitzbauer, Eva Herrmann, Christoph Sarrazin, Stefan Zeuzem & Martin-Walter Welker. (2017) Conversion From Sirolimus to Everolimus in Long-Term Liver Graft Recipients. The Journal of Clinical Pharmacology 57:7, pages 837-845.
Crossref
Crossref
Willem B. van Doesum, Lilli Gard, Frederike J. Bemelman, Johan W. de Fijter, Jaap J. Homan van der Heide, Hubert G. Niesters, Willem J. van Son, Coen A. Stegeman, Henk Groen, Annelies Riezebos-Brilman & Jan Stephan F. Sanders. (2017) Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy. Transplant Infectious Disease 19:3, pages e12687.
Crossref
Crossref
Ruben Vardanyan. 2017. Piperidine-Based Drug Discovery. Piperidine-Based Drug Discovery
103
125
.
Mathias Lutz & Stephan Mielke. (2016) New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease. British Journal of Clinical Pharmacology 82:5, pages 1171-1179.
Crossref
Crossref
Federico Bertuzzi, Mario Marazzi, Luciano G. De Carlis, Antonio G. Rampoldi, Matteo Bonomo, Barbara Antonioli, Marta C. Tosca, Marta Galuzzi, Andrea De Gasperi & Giacomo Colussi. (2016) Sustained Islet Allograft Function After Peritransplant Treatment Using Exenatide With and Without Everolimus. Transplantation 100:11, pages e117-e118.
Crossref
Crossref
Emaad Abdel-Kahaar, Mariana Kabakchiev, Bertram Hartmann, Eberhard Wieland & Maria Shipkova. (2016) Performance of a phosphoflow assay to determine phosphorylation of S6 ribosomal protein as a pharmacodynamic read out for mTOR inhibition. Clinical Biochemistry 49:15, pages 1181-1187.
Crossref
Crossref
Klemens Budde, Claudia Sommerer, Olesja Rissling, Maja T. Dieterlen & Markus J. Barten. (2016) Target Enzyme Activity and Phosphorylation of Pathway Molecules As Specific Biomarkers in Transplantation. Therapeutic Drug Monitoring 38:Supplement 1, pages S43-S49.
Crossref
Crossref
Aparna Dalal. (2016) Organ transplantation and drug eluting stents: Perioperative challenges. World Journal of Transplantation 6:4, pages 620.
Crossref
Crossref
Teruhiko Imamura, Koichiro Kinugawa, Daisuke Nitta, Osamu Kinoshita, Kan Nawata & Minoru Ono. (2016) Everolimus Attenuates Myocardial Hypertrophy and Improves Diastolic Function in Heart Transplant Recipients. International Heart Journal 57:2, pages 204-210.
Crossref
Crossref
Hallvard Holdaas, Paolo De Simone & Andreas Zuckermann. (2016) Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update. Journal of Transplantation 2016, pages 1-11.
Crossref
Crossref